The Oncotarget is a multidisciplinary journal that publishes medicinal content every week. The journal has been existing for the last ten years. As a medical journal, Oncotarget focuses more on oncology related topics. However, in the last few years, the journal has been able to grow, and currently, it is publishing in different areas and scope of medicines. These are; cardiology, cell biology, immunology, neuroscience, metabolism, endocrinology among other subjects. Since all these are fundamental areas of medicine, their posting procedures are all the same.The contents of this medical journal are peer reviewed on a weekly basis. Its first publication was made in the year 2010 by the impact journal publishers. The journal boasts of uniting different specialist in the field of medicine. The borders that long existed between various specialists have been reduced courtesy of this journal.
Oncotarget boasts of very high qualified editors in chief. The two editors are both doctors by profession from the Roswell Park Cancer Institute. For the last decade, the journal has been consistent and efficient in the provision of the required materials.The primary role of the journal is the provision of scientific evidence to various professionals in due time. The availability of data and evidence works to ensure that the peer reviews made are accurate, consistent and on time. The presence of timely review helps the journal to maximize its research impact. Oncotarget supports and encourages easier and faster sharing of the new inventions and discoveries made in the field of medicine. The primary role of the journal is to promote an elaborate plan for application of both clinical and basic science in the fight against diseases.
The role of the journal cannot, therefore, be downplayed. The consistent postings and citations is an indication that the journal is dedicated to safeguarding human life. It does so by promoting research by different specialists in various areas of medicine. The evidence and results obtained are then put to practical use. The results being a healthy and happy population.Oncotarget journal acts as the primary sponsor of Gordon Research Conference. In the year 2015/2016 alone, the journal had a total of 10542 citations, representing an impact factor of 5.008. The impact factor is used to show the number of times a journal is cited in scholarly articles. The particular higher incidence rate is an indication of the high level of academic importance that the journal attracts from the researchgate.net. In the first year of ranking, the Oncotarget journal attained a ranking of 4.78.